Introduces spectral flow cytometry and FITC combination concept
pp. 3-5
Presents experimental results combining FITC with various fluorochromes
p. 6
Summarizes findings on spectral flow cytometry capability
Orderingp. 7
Lists products used in this application
p. 2table, 18 rows
p. 3table, 19 rows
Table 1. Antibody information.
Marker
Fluorochrome
Clone
Vendor
Part number
CD45
PE
HI30
BioLegend
304007
CD45
BV510
HI30
BioLegend
304036
CD45
FITC
HI30
Agilent
8921014
CD3
PerCP-Cy5.5
SK7
Agilent
8931015
CD3
FITC
SK7
Agilent
8921016
CD4
BV421
RPA-T4
BioLegend
300532
CD4
Qdot705
S3.5
Thermo Fisher
Q10060
CD4
BB515
RPA-T4
BD
564419
CD4
Alexa Fluor 647
RPA-T4
BioLegend
300520
CD4
PE-Cy5.5
SK3
Thermo Fisher
35-0047-41
CD8
Pacific Blue
SK1
BioLegend
344718
CD8
FITC
SK1
Agilent
8920038
CD8
APC
SK1
Agilent
8920265
CD19
APC
HIB19
Agilent
8730007
CD19
PerCP-eFluor 710
J3-129
Thermo Fisher
46-0197-42
CCR6 (CD196)
PE
G034E3
BioLegend
353410
CXCR3 (CD183)
BV711
G025H7
BioLegend
353732
CXCR3 (CD183)
PE-Cy7
G025H7
BioLegend
353720
Table 5. Antibody information.
Group
Marker
Fluorochrome
Clone
Vendor
Part number
Violet-excited fluorochromes
CD4
BV510
OKT4
BioLegend
317444
Violet-excited fluorochromes
CD4
317444
RPA-T4
BioLegend
300532
Violet-excited fluorochromes
CD4
BV421
RPA-T4
BD
746541
Violet-excited fluorochromes
CD4
BV480
RPA-T4
Thermo Fisher
69-0049-42
Violet-excited fluorochromes
CD4
eFluor 506
RPA-T4
Thermo Fisher
79-0049-41
Violet-excited fluorochromes
CD11c
Pacific Orange
3.9
Thermo Fisher
48-0116-42
Violet-excited fluorochromes
CD4
PE
SK3
Agilent
8920028
Violet-excited fluorochromes
HLA-DR
CF568
TAL 1B5
Biotium
BNC682187-500
Violet-excited fluorochromes
CD4
PE-Dazzle 594
RPA-T4
BioLegend
300548
Violet-excited fluorochromes
CD4
PE-Alexa Fluor 610
S3.5
Thermo Fisher
MHCD0422
Violet-excited fluorochromes
CD4
PE-Fire 640
SK3
BioLegend
344663
Violet-excited fluorochromes
CD4
PE-Cy5
RPA-T4
BioLegend
300510
Violet-excited fluorochromes
CD117
PE-Cy5.5
YB5.B8
Novus
NBP1-43358PECY55
Violet-excited fluorochromes
CD25
PE-Alexa Fluor 700
CD25-3G10
Thermo Fisher
MHCD2524
Blue-excited fluorochromes
CD4
Alexa Fluor 700
RPA-T4
BioLegend
300526
Blue-excited fluorochromes
CD4
APC
SK3
Agilent
8931019
Blue-excited fluorochromes
CD4
Alexa Fluor 647
RPA-T4
BioLegend
300520
Blue-excited fluorochromes
CD4
Spark NIR 685
SK3
BioLegend
344658
Blue-excited fluorochromes
CD4
APC-R700
RPA-T4
BD
564975
Engineering Facts
12 facts · every claim linked to a page
Selection
The instrument's five-laser, 70-detector configuration defines which fluorochromes and panels can be supported, so it must be matched to the intended assay panel.
Laser and detector count determines the maximum panel complexity and which fluorochromes can be excited and resolved.
Source
“equipped with five lasers (349, 405, 488, 561, and 637 nm) and 70 fluorescence detectors.”
Selection
Fluorochromes with nearly identical spectra cannot be separated, so panel design must avoid such pairs regardless of instrument capability.
Prevents selection of fluorochrome pairs that the unmixing algorithm physically cannot resolve.
Source
“When FITC was used with Alexa Fluor 488 or KB520, the Similarity Index was 1.00, indicating almost identical spectra, which prevented signal resolution due to such high similarity.”
Performance
Spectral unmixing does not remove spillover spreading error, so closely overlapping fluorochromes will degrade resolution even when successfully unmixed.
Sets realistic expectations for panel performance and drives selection of minimally overlapping fluorochromes.
Source
“spectral spillover can propagate errors when measuring multiple fluorochromes. Spectral unmixing cannot eliminate these errors.”
Selection
The closer the emission spectra, the larger the spillover spreading error, so panel design should minimize spectral overlap.
Directly guides fluorochrome pairing decisions to preserve resolution in multicolor panels.
Source
“The closer the spectra are, the greater the spillover spreading error between fluorochromes.”
Performance
The system can resolve fluorochromes with a Similarity Index as high as 0.99, defining the practical resolution limit for panel design.
Establishes the upper bound of spectral similarity the instrument can handle when selecting fluorochromes.
Source
“NovoCyte Opteon was able to distinguish fluorochromes with a Similarity Index as high as 0.99 (FITC and BB515).”
Operation
Single-stained compensation beads must be acquired and unmixed to generate the spectral signature required for each fluorochrome.
Defines the reference-sample workflow needed before running multicolor unmixing experiments.
Source
“Unmixed single-stained compensation bead samples were used to generate spectrum signatures for each fluorochrome.”
Operation
Blood samples require lysis, centrifugation at 500 × g, washing, and resuspension in PBS with 1% PFA for consistent acquisition.
Specifies the centrifugation and wash protocol that affects sample quality and measurement reproducibility.
Source
“Centrifuge at 500 × g for 5 minutes at room temperature, discard the supernatant and wash the sample twice with PBS.”
Operation
Antibody staining must be incubated at room temperature for 15 minutes protected from light to preserve fluorochrome integrity.
Light protection and timing are required to avoid fluorochrome photobleaching and staining variability.
Source
“Vortex immediately and incubate at room temperature for 15 minutes, protected from light.”
Operation
PBMC antibody staining requires 30 minutes at room temperature in the dark, followed by two washes in staining buffer.
Defines the staining protocol needed for reproducible multicolor panel results.
Source
“Incubate for 30 minutes at room temperature, protected from light.”
Conformité
The instrument is restricted to research use and must not be used for diagnostic procedures.
Determines the permitted application scope and regulatory classification at installation site.
Source
“For Research Use Only. Not for use in diagnostic procedures.”
Selection
Spectral flow cytometry enables simultaneous use of highly overlapping fluorochromes, expanding panel design flexibility.
Justifies choosing spectral cytometry over conventional systems when panel density is a constraint.
Source
“spectral flow cytometry allows for simultaneous use of fluorochromes with highly overlapping spectra, enhancing flexibility in fluorochrome selection.”
Performance
As the Similarity Index decreases, fluorescent spreading error becomes smaller and resolution increases.
Provides the quantitative relationship used to rank candidate fluorochrome pairs during panel design.
Source
“As the Similarity Index decreases, the fluorescent spreading error becomes smaller, and the resolution increases.”